Market Cap

Fusion Antibodies plc Market Capitalization:

£2.5 Million

GBP as of Jan. 1, 2024

US$3.2 Million

business Fusion Antibodies plc Company Profile

Fusion Antibodies plc Main Stock Listing

LSE: FAB

Market Capitalization History of Fusion Antibodies plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Fusion Antibodies plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £2.5 M -83.68%
Jan. 1, 2023 £15.5 M -46.35%
Jan. 1, 2022 £28.9 M -18.30%
Jan. 1, 2021 £35.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Fusion Antibodies plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Fusion Antibodies plc has the following listings and related stock indices.


Stock: LSE: FAB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.